Literature DB >> 35465036

Paradoxical Effect on Epidermal Barrier of Anti-TNF-alpha Treatment for Psoriasis.

Giulio Gualdi1,2, Manfredo Bruni1,2, Federica Giuliani1,2, Paolo Gisondi1,2, Paolo Amerio1,2.   

Abstract

Background: Epidermal barrier defects have been described in psoriatic lesions. Transepidermal water loss (TEWL) is the measure of steady-state water vapor flux crossing the skin to the external environment, and it has been used extensively to characterize skin barrier function. We evaluated how biological treatments impact TEWL in with psocratic patients.
Methods: TEWL measurements were collected from psoriatic lesions and from adjacent unaffected skin areas before introducing a biological anti-tumor necrosis factor (TNF) alpha treatment and after six months of therapy.
Results: Our data show that the skin barrier function is restored after biologic therapy. Analysis of healthy skin values, indicated significant increases in TEWL.
Conclusion: A restoration of TEWL on psoriatic lesions was coupled with an alteration of this parameter in nonlesional skin of all patients, underscoring the general homeostatic effect of an anti-TNF on the integrity of skin barrier. These results suggest the need of an emollient therapy in patients with psoriasis undergoing systemic biological treatment.
Copyright © 2022. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Biologics; Epidermal barrier; Psoriasis; TEWL; TNF-alpha

Year:  2022        PMID: 35465036      PMCID: PMC9017665     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  9 in total

Review 1.  Psoriasis.

Authors:  Frank O Nestle; Daniel H Kaplan; Jonathan Barker
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

2.  The relationship between transepidermal water loss and skin permeability.

Authors:  Marta Machado; Teresa M Salgado; Jonathan Hadgraft; Majella E Lane
Journal:  Int J Pharm       Date:  2009-09-30       Impact factor: 5.875

3.  Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".

Authors:  V Brazzelli; T Barbagallo; F Prestinari; C Rona; A De Silvestri; V Trevisan; G Borroni
Journal:  Int J Immunopathol Pharmacol       Date:  2005 Oct-Dec       Impact factor: 3.219

4.  Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier.

Authors:  J M Jensen; S Schütze; M Förl; M Krönke; E Proksch
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 5.  The skin's barrier.

Authors:  J M Jensen; E Proksch
Journal:  G Ital Dermatol Venereol       Date:  2009-12       Impact factor: 2.011

6.  Abnormality of water barrier function in psoriasis. Role of ceramide fractions.

Authors:  S Motta; M Monti; S Sesana; L Mellesi; R Ghidoni; R Caputo
Journal:  Arch Dermatol       Date:  1994-04

7.  Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions.

Authors:  P Ettehadi; M W Greaves; D Wallach; D Aderka; R D Camp
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

8.  Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-alpha, and JNK.

Authors:  Bark-Lynn Lew; Yunhi Cho; Jungmin Kim; Woo-Young Sim; Nack-In Kim
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

9.  Expressive Suppression and Negative Affect, Pathways of Emotional Dysregulation in Psoriasis Patients.

Authors:  Cristina Ciuluvica; Mario Fulcheri; Paolo Amerio
Journal:  Front Psychol       Date:  2019-08-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.